Bicycle Therapeutics PLC
BCYC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761612
In the last 90 days, Bicycle Therapeutics PLC insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.
Holders of 5% or more of BCYC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bicycle Therapeutics PLC, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Forbion Growth Opportunities Fund II Cooperatief U.A. | 13G | 7.30%3.45M shares | New | Dec 19, 20241 filing | Dec 19, 2024 | SEC |
| Westfield Capital Management Co LP | 13G | 5.49%2.61M shares | New | Feb 11, 20251 filing | Feb 11, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
10 Schedule 13D and 13G filings on Bicycle Therapeutics PLC, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20258:57 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%359.7K shares | −0.60 ppfrom 5.59%Below 5% | Jun 30, 2025 | SEC |
| Aug 14, 20254:45 PM ET | Point72 Asset Management, L.P.and 2 others | 13G/A | 3.90%1.86M shares | −3.90 ppfrom 7.80%Below 5% | Jun 30, 2025 | SEC |
| Aug 14, 20258:45 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 2.42%1.20M shares | −3.25 ppfrom 5.67%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20254:34 PM ET | Point72 Asset Management, L.P.and 2 others | 13G/A | 7.80%3.74M shares | −1.10 ppfrom 8.90% | Mar 31, 2025 | SEC |
| May 15, 20253:08 PM ET | Armistice Capital, LLCand 1 other | 13G | 5.59%2.67M shares | New | Mar 31, 2025 | SEC |
| May 15, 20258:37 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 5.67%2.82M shares | −1.04 ppfrom 6.71% | Mar 31, 2025 | SEC |
| Feb 14, 20258:41 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 6.71%3.33M shares | – | Dec 31, 2024 | SEC |
| Feb 11, 20259:09 AM ET | Westfield Capital Management Co LP | 13G | 5.49%2.61M shares | New | Dec 31, 2024 | SEC |
| Dec 20, 20244:05 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 8.90%4.23M shares | New | Dec 13, 2024 | SEC |
| Dec 19, 20243:47 PM ET | Forbion Growth Opportunities Fund II Cooperatief U.A.and 1 other | 13G | 7.30%3.45M shares | New | Nov 21, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Bicycle Therapeutics PLC shares.
No Form 144 notices for Bicycle Therapeutics PLC are on file.